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Background
Automatic detection of tumors is a challenging task due
to the heterogeneous phenotypic and genotypic beha-
viors of cells within tumor types [1-3]. In recent years, a
number of research endeavors have been reported in lit-
eratures that exploit microarray gene expression data to
predict tissue/tumor types with high confidence [3-14].
However, in predicting tissue types, the above men-
tioned works neither explicitly considered correlation
among the genes nor the probable subgroups within the
known groups. In this work, our primary objective is to
develop an automated prediction scheme for tumors
based on DNA microarray gene expressions of tissue
samples.
Material and methods
The workflow to build the tumor prototypes is shown in
Fig. 1. Considering various sources of variation in array
measures, we estimate tumor-specific gene expression
measures using a two-way ANOVA model. Then, mar-
ker genes are identified using Wilcoxon [15] and Krus-
kal-Wallis [16] test. We then group the highly
correlated marker genes together. Then, we obtain
eigen-gene expressions measures [10] from each indivi-
dual gene group. At the end of this step, we replace the
gene expression measurements with eigen-gene expres-
sion values that conserve correlations among the
strongly correlated genes. We then divide the tissue
samples of known tumor types into subgroups. The CS
measure [17] is exploited to obtain the optimal number
of gene groups and tissue subgroups within each tissue
type. The centroids of these subgroups of tissue samples
represent the prototype of the corresponding tumor
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Figure 1 Simplified workflow to build the tumor prototypes.
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any medium, provided the original work is properly cited.type. Finally, any new tissue sample is predicted as the
tumor type of the closest centroid.
Results
To evaluate the proposed tumor prediction scheme, five
different gene microarray datasets [3-5,7-9] are used, all of
which were obtained using Affymetrix technology. We use
leave-one-out cross validation method. Table 1 shows a
summary of our experimental results for all the datasets.
We provide relevant intermediate results along with the
final classification accuracy. Finally, Table 2 shows the per-
formance comparison between our proposed prediction
scheme and the methods discussed in original works
[3,5,7-9] wherein the corresponding datasets are published.
We also compare our classification accuracies with those
of a Supervised Clustering method [4] for completeness.
Conclusions
In this work, we propose a novel, seamless, and inte-
grated technique of automatic tumor detection using
Affymetrix microarray gene expression data. We appro-
priately normalize the data by estimating tumor-specific
gene expression measures using an ANOVA model.
Furthermore, our novel tumor prediction scheme
explores molecular information such as probable corre-
lations among genes and probable unknown subgroups
within known tumor types. We demonstrate the efficacy
of our proposed scheme using five different Affymetrix
gene expression datasets.
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Table 1 Experimental results with different dataset
Dataset No. of Samples No. of Gene in each
chip
No. of Marker genes
with
q-value < 0.05
No. of eigen-gene
expression
No. of tissue
subgroups
Classification
Accuracy
Brain Tumor: A
[3]
Total: 42
Medullo: 10
Glioma: 10
AT/RTs: 10
Normal: 4
PNET: 8
6,817 1179 150 Medullo: 5
Glioma: 5
AT/RTs: 5
Normal: 2
PNET: 3
92%
Brain Tumor: B
[3]
Total: 34
Classic: 25
Desmoplastic: 9
6,817 29 11 Classic: 5
Desmoplastic: 3
97%
Brain Tumor: C
[3]
Total: 60
Survivor: 39
Deceased: 21
6,817 550 88 Survivor: 5
Deceased: 4
98%
Colon Cancer
[5]
Total: 62
Normal: 22
Tumor: 40
6,500 104 37 Normal: 7
Tumor: 9
97%
Prostate Cancer
[9]
Total: 102
Normal: 50
Tumor: 52
12,600 410 76 Normal: 5
Tumor: 9
99%
Leukemia [7] Total: 72
All: 47
AML: 25
7,129 60 20 All: 7
AML: 5
99%
Breast Cancer
[8]
Total: 38
ER +: 18
ER -: 20
7,129 109 38 ER +: 9
ER -: 7
97%
Table 2 Comparison of methods
Brain Tumor: A
[3]
Brain Tumor: B
[3]
Brain Tumor: C
[3]
Colon Cancer
[5]
Prostate Cancer
[9]
Leukemia
[7]
Breast Cancer
[8]
Original works 83% 97% 78% 90% 90% N/A 95%
Supervised
Clustering [4]
88% N/A N/A 84% 95% 100% 100%
Our Method 92% 97% 98% 97% 99% 99% 97%
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